These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11959339)

  • 1. Pravastatin improves low-density lipoprotein oxidation in renal transplantation.
    Cofan F; Zambon D; Laguna JC; Casals E; Ros E; Cofan M; Campistol JM; Oppenheimer F
    Transplant Proc; 2002 Feb; 34(1):389-91. PubMed ID: 11959339
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of pravastatin treatment on the evolution of extracoronary atherosclerosis in renal transplant patients.
    Cofan F; Gilabert R; Zambon D; Nunez I; Ros E; Cofan M; Campistol JM; Bru C; Oppenheimer F
    Transplant Proc; 2002 Feb; 34(1):384-8. PubMed ID: 11959338
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of the effect of two HMG CoA reductase inhibitors on LDL susceptibility to oxidation.
    Portal VL; Moriguchi EH; Vieira J; Schio S; Mastalir ET; Buffé F; Bortolini EB; Brüch RS; Rodrigues R
    Arq Bras Cardiol; 2003 Feb; 80(2):156-61, 150-5. PubMed ID: 12640509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Kuopio Atherosclerosis Prevention Study (KAPS): effect of pravastatin treatment on lipids, oxidation resistance of lipoproteins, and atherosclerotic progression.
    Salonen R; Nyssönen K; Porkkala-Sarataho E; Salonen JT
    Am J Cardiol; 1995 Sep; 76(9):34C-39C. PubMed ID: 7572684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pravastatin treatment on lipoprotein subclass profiles and particle size in the PLAC-I trial.
    Otvos JD; Shalaurova I; Freedman DS; Rosenson RS
    Atherosclerosis; 2002 Jan; 160(1):41-8. PubMed ID: 11755921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of two HMG-CoA reductase inhibitors (lovastatin and pravastatin) on serum lipids and lipoproteins.
    Richter WO; Jacob BG; Schwandt P
    Int J Tissue React; 1991; 13(2):107-10. PubMed ID: 1955291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Statins (HMG-CoA reductase inhibitors), cholesterol and stroke].
    Marta-Moreno J; Echeandia C; Oliveros-Cid A; Figuerola A; Mola S
    Rev Neurol; 1998 Nov; 27(159):827-30. PubMed ID: 9859160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal lipoprotein (a) and lipid profiles in renal allograft recipients: effects of treatment with pravastatin.
    Lye WC; Hughes K; Leong SO; Tan CC; Lee EJ
    Transplant Proc; 1995 Feb; 27(1):977-8. PubMed ID: 7879252
    [No Abstract]   [Full Text] [Related]  

  • 9. The ability of statins to protect low density lipoprotein from oxidation in hypercholesterolemic patients.
    Thallinger C; Urbauer E; Lackner E; Graselli U; Kostner K; Wolzt M; Joukhadar C
    Int J Clin Pharmacol Ther; 2005 Dec; 43(12):551-7. PubMed ID: 16372516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-density lipoprotein lowering and atherosclerosis progression: does more mean less?
    Shah PK
    Circulation; 2002 Oct; 106(16):2039-40. PubMed ID: 12379568
    [No Abstract]   [Full Text] [Related]  

  • 11. Prospective monitoring of lipid profiles in children receiving pravastatin preemptively after renal transplantation.
    Butani L
    Pediatr Transplant; 2005 Dec; 9(6):746-53. PubMed ID: 16269046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intensification in vivo of free radical oxidation of low density lipoproteins in plasma from patients with myocardial ischemia treated by HMG-CoA-reductase pravastatin and suppression of lipid peroxidation by ubiquinone Q10].
    Lankin VZ; Tikhaze AK; Kaminnaia VI; Kaminnyĭ AI; Konovalova GG; Kukharchuk VV
    Biull Eksp Biol Med; 2000 Feb; 129(2):176-9. PubMed ID: 10732240
    [No Abstract]   [Full Text] [Related]  

  • 13. Does pravastatin safely and effectively improve lipid profiles in children who have received a kidney transplant?
    Silverstein DM
    Nat Clin Pract Nephrol; 2006 Jun; 2(6):306-7. PubMed ID: 16932448
    [No Abstract]   [Full Text] [Related]  

  • 14. Baseline levels of low-density lipoprotein cholesterol and lipoprotein (a) and the AvaII polymorphism of the low-density lipoprotein receptor gene influence the response of low-density lipoprotein cholesterol to pravastatin treatment.
    Lahoz C; Peña R; Mostaza JM; Laguna F; García-Iglesias MF; Taboada M; Pintó X
    Metabolism; 2005 Jun; 54(6):741-7. PubMed ID: 15931608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins improve visual field alterations related to hypercholesterolemia.
    Alcalá A; Jansen S; Téllez T; Gómez-Huelgas R; Pérez O; Egido J; Farkouh ME
    Atherosclerosis; 2010 Apr; 209(2):510-4. PubMed ID: 19892351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up.
    Vallejo-Vaz AJ; Robertson M; Catapano AL; Watts GF; Kastelein JJ; Packard CJ; Ford I; Ray KK
    Circulation; 2017 Nov; 136(20):1878-1891. PubMed ID: 28877913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of atorvastatin therapy and conversion to tacrolimus on hypercholesterolemia and endothelial dysfunction after renal transplantation.
    Wissing KM; Unger P; Ghisdal L; Broeders N; Berkenboom G; Carpentier Y; Abramowicz D
    Transplantation; 2006 Sep; 82(6):771-8. PubMed ID: 17006324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for stroke and lipid-lowering effect of pravastatin on the risk of stroke in Japanese patients with hypercholesterolemia: analysis of data from the MEGA Study, a large randomized controlled trial.
    Uchiyama S; Nakaya N; Mizuno K; Ohashi Y; Tajima N; Kushiro T; Teramoto T; Nakamura H;
    J Neurol Sci; 2009 Sep; 284(1-2):72-6. PubMed ID: 19423132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidized low-density lipoprotein in children with familial hypercholesterolemia and unaffected siblings: effect of pravastatin.
    Rodenburg J; Vissers MN; Wiegman A; Miller ER; Ridker PM; Witztum JL; Kastelein JJ; Tsimikas S
    J Am Coll Cardiol; 2006 May; 47(9):1803-10. PubMed ID: 16682304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cerivastatin on lipid profiles, lipid peroxidation and platelet and endothelial activation in renal transplant recipients.
    Caillard S; Leray C; Kunz K; Gachet C; Offner M; Wiesel ML; Hannedouchte T; Cazenave JP; Moulin B
    Transplant Proc; 2000 Dec; 32(8):2787-8. PubMed ID: 11134806
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.